Category: Blog Post
🤚🏻 Five for Friday – Meet 5 CCA Scientists
Home / Blog / [wpbb post:title] Finding a cure for a disease as rare and complex as cholangiocarcinoma demands creative…
Cure Cholangiocarcinoma Think Tank (C2T2)
The Cholangiocarcinoma Foundation has published a white paper from the first Cure Cholangiocarcinoma Think Tank (C2T2 ) meeting, which gathered…
🤚🏻 Five for Friday – Meet Some of CCF's Valued Experts
Home / Blog / [wpbb post:title] Collaboration is essential for cholangiocarcinoma research. This month, join us in appreciating our medical…
Living with #CCAHope
At the 9th Annual Cholangiocarcinoma Foundation Conference, the communications team introduced a new social media campaign, "Living with #CCAHope." CCF…
Happy Thanksgiving Canada
Dear Friend, Last Canadian Thanksgiving, I enjoyed dinner with my family. It was a small gathering of my husband, mom,…
🤚🏻 Five for Friday – 6 CCF Accomplished Medical Professionals
Home / Blog / [wpbb post:title] CCF collaborates with many physicians, clinicians, and researchers whose accomplishments in the cholangiocarcinoma field…
Man runs a marathon each month in honor of his wife, who has been diagnosed with rare bile duct cancer twice
Delorean Ostrom's 'Racing for Hope' campaign raises funds to advance cholangiocarcinoma research with proceeds benefiting the Cholangiocarcinoma Foundation SALT LAKE…
Monthly Scientific Update – October 2022 (Breath Tests Could Help Diagnose Cholangiocarcinoma: An Innovative Approach to Early Detection)
Kelly Butler, Dr. Reham Abdel-Wahab Cholangiocarcinoma (CCA) is often detected at an advanced stage that is difficult to treat. Early…
Racing for Hope Journal Entry 21
When I got this idea to run a marathon a month, I knew it would be hard. I really underestimated…
Collaborative Research Groups
CCF has formed collaborative groups that work to achieve its mission to find a cure and improve the quality of…
Racing for Hope Journal Entry 20
Monday, September 12th, 2022 Mandy is having surgery to remove lymph nodes that are of concern. Walking into the hospital…
New standard of care for rare cancer with FDA approval of Imfinzi applauded by Cholangiocarcinoma Foundation
AstraZeneca TOPAZ-1 Phase III trial showed adding immunotherapy to standard chemotherapy increases overall survival in advanced biliary tract cancer The…